If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It’s about time they secured and announced contract news instead of touring the world presenting !
https://www.linkedin.com/posts/fusion-antibodies-plc_bio2024-bio2024-networking-activity-7193596858961690625-gtub?utm_source=share&utm_medium=member_ios
😂
I presume they're May bugs?😏
Yes great interview, if OptiMAL gets successfully valuated by NCI then this will be a serious multibagger, mcap of £3.24m is the perfect time to get in before the inevitable herd arrives.
Really good interview, some good things are going to come out from FAB in the coming weeks and months.
Plenty of cash in the bank, working with some huge companies and more orders in the pipeline. I will continue to add down here!
My buy showing at 11:54 as sells
Interesting at 03:12 in the interview he says that they’re gaining traction in vet medicine “as we speak”. Wonder is there some news in that space to come shortly
Totally, if you think forward the interim results RNS is already going to be saying that H1 revenues are up over 50% on the previous year. We’re moving forward and upwards and the market is just going to take time to wake up. They just didn’t communicate well in the trading update.
Super upbeat that
The past is History, we know that, we can reflect on that and learn from it so that we can build a better future!
It seems like FAB have turned a corner and are optimistic about the future, it’s this future that excites me and makes me feel that things, including the SP, can only get better!
GLA
Anyone else think the last trading update was a kitchen sink job and they are now trying to focus everyone on the future, not the past year?
If delayed contracts are just delayed, then they will boost what we are being told is a growing sales leads, sales pipeline and orderbook...
Chris, you said this, what grant are you referring to?
RE: Moving up!2 May 2024 14:10
Has to really, imagine when that grant lands
And so the pr begins
Anyone any idea why? 🤔
AXX 10 month high. Are the Dogs going to start a fightback?
Haha yes
Not as strong as the 29 code....
1 code there for believers
"The net proceeds receivable by the Company pursuant to the Placing are approximately £1.24 million"
Very tempting to buy down here, purely based to discount to last raise and the shake out attempt the past few days. Looks like they need some news soon.
Didn’t someone say to buy Miri here yesterday! Hope nobody did. What a horrific placement. Done at a near 50% discount. Nearly as bad as fab placing while back.
The RNS was intended to put good news out there as to the changing environment for pharma etc. unfortunately some read it as negative so this presentation should enhance the positive outlook.
Opportunity to smash it out the park and FAB arriving on many investors radars. Let’s hope so. Market cap minuscule for what they have.